Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 8.1124.0847.24-21.1914.78

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 8.11 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar20258.11
Mar202424.08
Mar202347.24
Mar2022-21.19
Mar202114.78

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 8.11
-66.32
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19
Negative
Mar2021 14.78 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹120,284.3 Cr -1.3% 0.8% 11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,170.0 Cr -2.6% -0.9% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr 0.2% -3.5% -5.8% Stock Analytics
MANKIND PHARMA ₹95,320.4 Cr -5.6% -5.8% -11.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.3%

0.8%

11.7%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses